RxDoctor Payments Data

Hughes Helm, MD

Family Medicine · Bayboro, NCNPI 1336368737

Payments from drug & device makers

$5,793in general payments, 2019–2025

Across 339 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$735
  • GSK$663
  • Novo Nordisk$489
  • Lilly USA, LLC$422
  • AbbVie$405
  • Johnson & Johnson$293
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$5,793100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,793 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$267,243
Medicare patients
738
Services billed
8,009

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban251$123,404
OzempicSemaglutide71$98,977
MounjaroTirzepatide81$84,081
FarxigaDapagliflozin Propanediol109$73,335
TrulicityDulaglutide39$60,235
JanuviaSitagliptin Phosphate48$54,674
OtezlaApremilast21$50,566
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$45,690
JardianceEmpagliflozin46$42,993
MyrbetriqMirabegron66$35,279
AptiomEslicarbazepine Acetate28$32,774
XareltoRivaroxaban39$29,560
LinzessLinaclotide37$20,617
GemtesaVibegron26$17,859
TrintellixVortioxetine Hydrobromide22$16,315

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$422$144,316120 claims
PfizerEliquis$140$123,404251 claims
Novo NordiskOzempic$489$98,97771 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Shingrix$663$76,887124 claims
AstraZenecaFarxiga$735$73,335109 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Tradjenta, Combivent Respimat$129$67,963101 claims
MerckJanuvia, Belsomra$125$59,59459 claims
AmgenOtezla$239$50,56621 claims
Astellas Pharma US IncMyrbetriq$101$35,27966 claims
Johnson & JohnsonXarelto$293$29,56039 claims
AbbVieLinzess$405$20,61737 claims
Sumitomo Pharma America, Inc.Gemtesa$27$17,85926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Bayboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →